International Registry of Stem Cell Treatment Providers  ·  2026 Clinical Edition  ·  1,507 Verified Clinics Across 73 Countries
StemCell Registry
Global Clinical Directory
1,507 Providers
73 Countries
Edition 2026
FAQ
StemCell RegistryCanada › Hôpital Maisonneuve-Rosemont (HMR) – Hematopoietic Stem Cell Transplant Program

Hôpital Maisonneuve-Rosemont (HMR) – Hematopoietic Stem Cell Transplant Program

A high-volume publicly funded haematopoietic cell transplant programme at Hôpital Maisonneuve-Rosemont in Montreal, part of the CIUSSS de l'Est-de-l'Île-de-Montréal.

Medical Disclaimer: This profile is compiled for informational purposes only and is not medical advice, a clinical endorsement, or a statement that any treatment is proven or approved. Stem cell therapies vary widely in regulatory status and evidence. Consult a qualified physician before pursuing treatment.

Overview

Hôpital Maisonneuve-Rosemont in Montreal runs a haematopoietic cell transplant programme within the CIUSSS de l'Est-de-l'Île-de-Montréal, Quebec's east-end integrated health and social services centre. According to the programme page, it carries out between 185 and 200 transplants a year and serves local, regional and supra-regional populations.

The site describes two forms of transplant. In an autologous transplant, the patient's own cells are harvested before high-dose chemotherapy and returned afterwards to restart bone marrow function. In an allogeneic transplant, cells come from a healthy donor or from umbilical cord blood, and the site says this is used to treat serious diseases, particularly blood cancers.

The page also sets out how cells are collected: from the bloodstream using apheresis equipment, by bone marrow aspiration carried out under anaesthesia, or from umbilical cord blood. It describes the programme as integrating hospital care units, oncology centres, apheresis services and transplant coordination departments.

The page gives a direct telephone extension and fax number. It does not name individual physicians, does not state accreditation on that page, and says nothing about cost; the service sits within Quebec's publicly funded health system. The site is published in French.

At a Glance

Location
Montreal, QC, Canada
Address
5415 Boul. de l'Assomption, Montreal, QC H1T 2M4 | FACT-accredited; also CETC (Centre of Excellence in Cell Therapy) onsite; affiliated with Université de Montréal
Google Rating
2.6 ★ (1168 reviews)
Languages
['French']

Services and Treatments Offered

  • Autologous haematopoietic cell transplant, using the patient's own harvested cells
  • Allogeneic haematopoietic cell transplant, using cells from a healthy donor or umbilical cord blood
  • Stem cell collection by apheresis from the bloodstream
  • Bone marrow aspiration under anaesthesia for cell collection
  • Umbilical cord blood transplantation
  • Transplant coordination and follow-up care

Conditions Treated

The page states that the procedure treats bone marrow and immune system disorders, most often with the aim of curing the underlying condition.

Blood cancersDisorders of the bone marrowDisorders of the immune system

Cell Sources and Technologies

The site states that the programme transplants haematopoietic cells taken either from the patient or from a healthy donor or umbilical cord blood, collected by apheresis, bone marrow aspiration or cord blood harvest.

Autologous haematopoietic cells — harvested from the patient before high-dose chemotherapy and returned afterwards, according to the siteAllogeneic haematopoietic cells — from a healthy donor, according to the siteUmbilical cord blood cells — used as an allogeneic source, according to the sitePeripheral blood cells collected by apheresis, and bone marrow collected by aspiration under anaesthesia, as the two collection methods named

Physicians and Clinical Team

The programme page does not name individual physicians.

Dr. Denis-Claude Roy (Director IHOT; hematopoietic transplantcellular therapy); Dr. Sandra Cohen (stem cell transplant); Dr. Sylvie Lachance; Dr. Isabelle Fleury (CAR-T pioneer); Dr. Jean Roy; Dr. Jean-Sébastien Delisle

Facility and Patient Experience

The programme is based at Hôpital Maisonneuve-Rosemont in Montreal, part of the CIUSSS de l'Est-de-l'Île-de-Montréal. The site describes the programme as drawing together hospital care units, oncology centres, apheresis services and transplant coordination departments, and gives a direct telephone extension and fax number. It does not describe the ward premises or bed numbers, and states no accreditation on this page.

  • Location: Hôpital Maisonneuve-Rosemont, Montreal, Quebec
  • Telephone: 514-252-3400, extension 6580
  • Fax: 514-252-3556
  • Between 185 and 200 transplants performed each year, according to the site
  • Serves local, regional and supra-regional populations, according to the site
  • Part of the CIUSSS de l'Est-de-l'Île-de-Montréal
  • Site published in French

Cost and Payment

The page says nothing about cost. It is part of Quebec's publicly funded hospital system, but the site itself makes no statement about fees.

Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.

Other Providers in Canada

View all providers in Canada →